Thursday, November 4, 2010 |
| 12h00 |
Registration Opens |
|
| |
Session I: Stem Cells from Cord Blood and Placenta - Chair: C. Chabannon |
|
| 14h00 - 14h30 |
Cord blood stem cell biology and means to enhance hematopoietic stem cell function for more efficient engrafting capability |
H.E. Broxmeyer (Indianapolis) |
| 14h30 - 15h00 |
iPS from cord blood |
J.C. Ispizua-Belmonte
(San Diego) |
| 15h00 - 15h30 |
Production of USSC from cord blood and possible clinical developments |
G. Kogler (Dusseldorf) |
| 15h30 - 16h00 |
The role of Notch in haematopoiesis basic biology and clinical implications |
I. Bernstein (Seattle) |
| 16h00 - 16h20 |
Notch induced ex vivo expansion of hematopoietic stem/progenitor cells clinical applications updates |
C. Delaney (Seattle) |
| 16h20 - 16h45 |
Coffee break |
|
| |
Session II: Non hematopoietic stem cells from cord blood and placenta - Chair: H.E. Broxmeyer |
|
| 16h45 - 17h10 |
The role of INFg for neurological differentiation from HUCB |
A. Nagler (Tel Hashomer) |
| 17h10 - 17h35 |
Endothelial cells isolation from cord blood for treatment of vascular diseases |
G. Uzan (Paris) |
| 17h35 - 18h00 |
Cord blood endothelial progenitors: perspectives for cell therapy of cardiovascular disorders |
F. Dignat - George (Marseille) |
| 18h00 - 18h25 |
Placental perfusion experiments: what is it? What else? |
F. Forestier (Paris) |
| 18h25 - 18h45 |
Hematopoietic and muscular potencial of amiotic fluid derived stem cells |
I Andre-Schmutz (Paris) |
| 19h00 - 20h00 |
Opening Ceremony |
|
| |
Welcome Cocktail |
|
Friday, November 5, 2010 |
| |
Session II: Clinical applications in non hematopoietic diseases - Chair: E.J. Shpall |
|
| 08h30 - 09h00 |
Status of a clinical trial of autologous cord blood cells for the treatment of cerebral palsy and other acquired brain injuries |
J. Kurtzberg (Durham) |
| 09h00 - 09h30 |
Application of stem cells in the treatment of epidermolysis bullosa |
J. Wagner (Minneapolis) |
| 09h00 - 10h00 |
Cell therapy of burns |
J.J. Lataillade (Clamart) |
| 10h00 - 10h30 |
Coffee break |
|
| |
Session III: Graft facilitation - Chair: W. Arcese |
|
| 10h30 - 11h00 |
Stem cell regulation by bFGF, kit ligand and myeloid cells |
T. Lapidot (Rehovot) |
| 11h00 - 11h30 |
PGE for graft facilitation |
L. Pelus (Indianapolis) |
| 11h30 - 12h00 |
Enhanced engraftment with cord blood expansion and fucolysation |
E.J. Shpall (Houston) |
| 12h00- 12h30 |
Intrabone infusion of cord blood cells |
F. Frassoni (Genova) |
| 12h30 - 13h00 |
Use of third party cells to facilitate engraftment |
M.N. Fernandez (Madrid) |
| 13h00 - 14h00 |
Lunch and Poster Viewing |
|
| |
Session III: Graft facilitation - Chair: J. Kurtzberg |
|
| 14h00 - 14h30 |
Results of double cord blood transplant |
V. Rocha (Paris) |
| 14h30 - 15h00 |
Mechanism of graft facilitation with double cord transplant |
J. Wagner (Minneapolis) |
| 15h00 - 15h30 |
Should the number of collected CD34+ cells be considered major criteria for UCB unit choice in adults? |
G. Sanz (Valencia) |
| 15h30 - 16h00 |
Role of HLA in cord blood transplant |
E. Petersdorf (Seattle) |
| 16h00 - 16h30 |
Coffee break |
|
| |
Session IV: Immunological properties of cord blood - Chair: F. Locatelli |
|
| 16h30 - 17h00 |
Potential immunotherapeutic properties of cord blood |
A. Madrigal (London) |
| 17h00 - 17h30 |
Virus and tumour specific cord blood T cells |
C. Bollard (Houston) |
| 17h30 - 18h00 |
Use of cord blood cells for anti tumour and anti infectious immunotherapy |
F. Falkenburg (Leiden) |
| 18h00 - 18h20 |
Comparison between MSC derived from bone marrow and cord blood |
M.E. Bernardo (Torino) |
Saturday, November 6, 2010 |
| |
Session V: Clinical results I - Chair: E. Gluckman
|
|
| 09h00 - 09h30 |
Comparison of haploidentical and cord blood in children with immune deficiencies |
M. Cavazzana-Calvo (Paris) |
| 09h30 - 10h00 |
Impact of stem cell source for transplant in adults with leukemia |
M. Eapen (Milwaukee) |
| 10h00 - 10h25 |
Comparison of cord blood transplants with other sources of cells in Hurler disease |
J. Boelens (Utrecht) |
| 10h25- 10h45 |
Coffee break |
|
| 10h45 - 11h10 |
Conditioning for cord blood transplant |
E. Gluckman (Paris) |
| 11h10 - 11h35 |
Reduced intensity conditioning French results |
B. Rio (Paris) |
| 11h35 - 12h00 |
Cord blood transplant in patients with AML in remission |
W. Arcese (Rome) |
| 12h00 - 12h25 |
Single cord blood transplantation followed by myeloablative regimen for adults - Recent progress in Japan |
S. Takahashi (Tokyo) |
| 12h30 - 14h00 |
|
|
| |
CLINICAL RESULTS II - Chair: V. Rocha |
|
| 14h00 - 14h20 |
Incidence and risk factors for secondary autoimmune diseases after CBT |
D. Farge (Paris) |
| 14h20 - 14h40 |
Results of cord blood transplant in children with malignancies |
G. Michel (Marseille) |
| 14h40 - 15h00 |
Results of cord blood transplant in children with acute lymphoid leukemia |
A.L. Ruggeri (Paris) |
| 15h00 - 15h20 |
Incidence and risk factors of chronic GVH after unrelated cord blood transplant in adults and children |
A. Crotta (Milan) |
| 15h20 - 15h40 |
Discussion |
G. Michel (Marseille) |
| 15h40 - 16h00 |
Coffee break |
|
| |
Session VI: Related cord blood transplants - Chair: G. Sanz |
|
| 16h00 - 16h30 |
Related cord blood transplant in hemoglobinopathies |
F. Locatelli (Rome) |
| 16h30 - 17h00 |
Gene therapy for hemoglobinopathies |
P. Leboulch (Paris) |
| 17h00 - 17h30 |
Directed cord blood banking |
E. Gluckman (Paris) |
| 17h30 - 18h30 |
Presentation of selected abstracts |
|
Sunday, November 7, 2010 |
| |
Session VII: Regulatory organisational ethical aspects - Chair: E. Baudoux |
|
| 08h30 - 08h50 |
Netcord organisation |
E. Baudoux (Liège) |
| 08h50 - 09h15 |
Optimising cord blood inventories |
S. Querol (Barcelona) |
| 09h15 - 09h40 |
Advanced medicinal products and cord blood banking |
C. Chabannon (Marseille) |
| 09h40 - 10h00 |
Predictivity of cord blood units quality
Assessments on Unrelated Cord Blood Transplant outcome
|
A. Picardi (Rome) |
| 10h00- 10h30 |
Coffee break |
|
| 10h30 - 10h50 |
Implication of licensure on international exchange of cord blood units |
M. Boo (Minneapolis) |
| 10h50 - 11h10 |
FACT Netcord and WMDA accreditation |
C. Navarette (London) |
| 11h10 - 11h40 |
Socio economic aspects |
P. Rebulla (Milan) |
| 11h40 - 12h10 |
Eurocord registry |
V. Rocha (Paris) |
| 12h10 - 12H40 |
CIBMTR |
M. Horowitz (Milwaukee) |
| 12h40 - 13h10 |
Ethical aspects |
P. Le Coz (Marseille) |
13h15 |
Closure of meeting |
|
| |